Stay updated on PROST: rhPro-UK in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the PROST: rhPro-UK in Acute Stroke Clinical Trial page.

Latest updates to the PROST: rhPro-UK in Acute Stroke Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.8.0 to v3.8.1, indicating a site software update.SummaryDifference0.0%

- Check9 days agoChange DetectedThe PROST phase 3 trial record is available, describing a comparison of recombinant human urokinase and alteplase for acute ischemic stroke, along with participant criteria, trial sites, and measured outcomes.SummaryDifference62%

- Check16 days agoChange DetectedThe displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedAn NIH-wide notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study content remains inaccessible behind a 403 error.SummaryDifference1%

- Check44 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the content is blocked. As a result, the usual study details are not visible at this time.SummaryDifference18%

Stay in the know with updates to PROST: rhPro-UK in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROST: rhPro-UK in Acute Stroke Clinical Trial page.